Director at Nuwellis (NUWE) granted 6,744 stock options at $1.16

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Nuwellis, Inc. director Archelle Georgiou Feldshon received a grant of nonstatutory stock options covering 6,744 shares of common stock. The options have an exercise price of $1.16 per share and expire on April 27, 2036.

The award vests in 12 approximately equal monthly installments starting one month after the grant date, so all 6,744 options will be fully vested on the one-year anniversary of the grant. This is a compensation-related equity grant, not an open-market share purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Feldshon Archelle Georgiou

Role null

Type	Security	Shares	Price	Value
Grant/Award	Nonstatutory Stock Option (right to buy)	6,744	$0.00	--

Holdings After Transaction: Nonstatutory Stock Option (right to buy) — 6,744 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Options granted: 6,744 options Exercise price: $1.16 per share Expiration date: April 27, 2036 +1 more

4 metrics

Options granted 6,744 options Nonstatutory stock option grant to director

Exercise price $1.16 per share Exercise price of nonstatutory stock options

Expiration date April 27, 2036 Option term end date

Vesting schedule 12 monthly installments over 1 year Vests starting one month after grant

Key Terms

Nonstatutory Stock Option (right to buy), exercise price, vesting, expiration date

4 terms

Nonstatutory Stock Option (right to buy) financial

"security_title: "Nonstatutory Stock Option (right to buy)""

exercise price financial

"conversion_or_exercise_price: "1.1600" per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"Vests in 12 approximately equal consecutive monthly increments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

expiration date financial

"expiration_date: "2036-04-27T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Form 4 Insider Transactions: What Each Field Means →

04/29/2026 - 05:16 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Feldshon Archelle Georgiou

(Last)

(First)

(Middle)

12988 VALLEY VIEW ROAD

(Street)

EDEN PRAIRIE

MINNESOTA

55344

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nuwellis, Inc. [ NUWE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Nonstatutory Stock Option (right to buy)	$1.16	04/28/2026		A		6,744		⁽¹⁾	04/27/2036	Common Stock	6,744	$0	6,744	D

Explanation of Responses:

1. Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant.

	/s/ Neil Ayotte, by Power of Attorney	04/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did the Nuwellis (NUWE) director acquire in this Form 4 filing?

The director received 6,744 nonstatutory stock options to buy Nuwellis common shares at an exercise price of $1.16. This is an equity award classified as a grant, not an open-market purchase of existing shares.

What is the exercise price of the Nuwellis (NUWE) stock options granted?

The nonstatutory stock options have an exercise price of $1.16 per share. This means the director can buy Nuwellis common stock at $1.16 once the options vest, any time before they expire on April 27, 2036.

How do the Nuwellis (NUWE) director’s stock options vest over time?

The 6,744 options vest in 12 approximately equal monthly installments starting one month after the grant date. All options are scheduled to be fully vested on the one-year anniversary of the grant, assuming continued service through each vesting date.

When do the newly granted Nuwellis (NUWE) stock options expire?

The options are scheduled to expire on April 27, 2036, if not exercised earlier. After that expiration date, any unexercised options become worthless and can no longer be used to purchase Nuwellis common stock.

Is this Nuwellis (NUWE) Form 4 a stock purchase or a compensation grant?

This Form 4 reflects a compensation-related grant of nonstatutory stock options, coded as a grant or award acquisition. It does not show an open-market buy or sell of Nuwellis common shares by the director.